Olanzapine SmeltTab Viatris 10 mg
As listed in the register: Olanzapine SmeltTab Viatris 10 mg, orodispergeerbare tabletten
10 mg · orodispergeerbare tablet
- Prescription only
- Pain, sleep, mood, epilepsy and the brain
- Active substance
- Olanzapine
- Made by
- Viatris Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Olanzapine). It describes the substance, not this exact product.
The mechanism of action of olanzapine, in the listed indications is unclear.
However, the efficacy of olanzapine in schizophrenia could be mediated through a combination of dopamine and serotonin type 2 (5HT 2 ) antagonism.
It is eliminated extensively by first pass metabolism, with approximately 40% of the dose metabolized before reaching the systemic circulation.
Specific Populations Renal Impairment — Because olanzapine is highly metabolized before excretion and only 7% of the drug is excreted unchanged, renal dysfunction alone is unlikely to have a major impact on the pharmacokinetics of olanzapine.
Food does not affect the rate or extent of olanzapine absorption.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-09-08
Safety of the active substance
From the US prescribing label for the same active substance (Olanzapine). It describes the substance, not this exact product.
WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.
- None with olanzapine tablets monotherapy..
- When using olanzapine and fluoxetine in combination, also refer to the Contraindications section of the package insert for Symbyax..
- For specific information about the contraindications of lithium or valproate, refer to the Contraindications section of the package inserts for these other products..
- None with olanzapine monotherapy.
Most common adverse reactions (≥5% and at least twice that for placebo) associated with: Oral Olanzapine Monotherapy: Schizophrenia (Adults) – postural hypotension, constipation, weight gain, dizziness, personality disorder, akathisia.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States39 matching products
European UnionNo exact match for this strength and form
Spain85 matching products
- ZYPREXA VELOTAB 10 mg · comprimido bucodispersable13 makers
- ZYPREXA 10 mg · comprimido12 makers
- OLANZAPINA APOTEX 10 mg · comprimido bucodispersable4 makers
- ZALASTA 10 MG olanzapina · comprimido bucodispersable4 makers
- OLANZAPINA ALTER 10 mg · comprimido bucodispersable2 makers
- OLANZAPINA AUROVITAS 10 mg · comprimido bucodispersable2 makers
- OLANZAPINA COMBIX 10 mg · comprimido bucodispersable2 makers
- OLANZAPINA KRKA 10 mg · comprimido bucodispersable2 makers
France27 matching products
- OLANZAPINE ARROW 10 mg · comprimé2 makers
- OLANZAPINE BIOGARAN 10 mg · comprimé enrobé2 makers
- OLANZAPINE CRISTERS 10 mg · comprimé enrobé2 makers
- OLANZAPINE EG 10 mg · comprimé orodispersible2 makers
- OLANZAPINE EVOLUGEN 10 mg · comprimé orodispersible2 makers
- OLANZAPINE SANDOZ 10 mg · comprimé orodispersible2 makers
- OLANZAPINE TEVA 10 mg · comprimé orodispersible2 makers
- OLANZAPINE VIATRIS 10 mg · comprimé orodispersible2 makers
Canada26 matching products
- OLANZAPINE 10 mg · tablet4 makers
- OLANZAPINE ODT 10 mg · tablet (orally-disintegrating)3 makers
- AG-OLANZAPINE FC 10 mg · tablet
- AG-OLANZAPINE ODT 10 mg · tablet (orally-disintegrating)
- APO-OLANZAPINE 10 mg · tablet
- APO-OLANZAPINE ODT 10 mg · tablet (orally-disintegrating)
- AURO-OLANZAPINE ODT 10 mg · tablet (orally-disintegrating)
- JAMP OLANZAPINE FC 10 mg · tablet
SwitzerlandNo exact match for this strength and form
Details
| Made by | Viatris Limited |
|---|---|
| Active substance | Olanzapine |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Strength | 10 mg |
| Form | orodispergeerbare tablet |
| Classification | N05AH03 · Pain, sleep, mood, epilepsy and the brain |
| Route | oraal gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| Name in the register | Olanzapine SmeltTab Viatris 10 mg, orodispergeerbare tabletten |
| RVG | 108413 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.